Format
Sort by

Send to

Choose Destination

Search results

Items: 11

1.

Zika virus epidemic: Africa should not be neglected.

Meda N, Salinas S, Kagoné T, Simonin Y, Van de Perre P.

Lancet. 2016 Jul 23;388(10042):337-8. doi: 10.1016/S0140-6736(16)31103-5. No abstract available.

PMID:
27477155
2.

Estimation of HIV-1 DNA Level Interfering with Reliability of HIV-1 RNA Quantification Performed on Dried Blood Spots Collected from Successfully Treated Patients.

Zida S, Tuaillon E, Barro M, Kwimatouo Lekpa Franchard A, Kagoné T, Nacro B, Ouedraogo AS, Bolloré K, Sanosyan A, Plantier JC, Meda N, Sangaré L, Rouzioux C, Rouet F, Kania D.

J Clin Microbiol. 2016 Jun;54(6):1641-3. doi: 10.1128/JCM.03372-15.

3.

Prevention of mother-to-child HIV-1 transmission in Burkina Faso: evaluation of vertical transmission by PCR, molecular characterization of subtypes and determination of antiretroviral drugs resistance.

Sagna T, Bisseye C, Compaore TR, Kagone TS, Djigma FW, Ouermi D, Pirkle CM, Zeba MT, Bazie VJ, Douamba Z, Moret R, Pietra V, Koama A, Gnoula C, Sia JD, Nikiema JB, Simpore J.

Glob Health Action. 2015 Jan 27;8:26065. doi: 10.3402/gha.v8.26065.

4.

A variant of DC-SIGN gene promoter associated with resistance to HIV-1 in serodiscordant couples in Burkina Faso.

Kagoné TS, Bisseye C, Méda N, Testa J, Pietra V, Kania D, Yonli AT, Compaoré TR, Nikiéma JB, de Souza C, Simpore J.

Asian Pac J Trop Med. 2014 Sep;7S1:S93-6. doi: 10.1016/S1995-7645(14)60211-X.

5.

Sentinel surveillance of influenza in Burkina Faso: identification of circulating strains during 2010-2012.

Tarnagda Z, Yougbaré I, Ilboudo AK, Kagoné T, Sanou AM, Cissé A, Médah I, Yelbéogo D, Nzussouo NT.

Influenza Other Respir Viruses. 2014 Sep;8(5):524-9. doi: 10.1111/irv.12259.

6.

Field evaluation of dried blood spots for routine HIV-1 viral load and drug resistance monitoring in patients receiving antiretroviral therapy in Africa and Asia.

Monleau M, Aghokeng AF, Eymard-Duvernay S, Dagnra A, Kania D, Ngo-Giang-Huong N, Touré-Kane C, Truong LX, Chaix ML, Delaporte E, Ayouba A, Peeters M; ANRS 12235 Study Group..

J Clin Microbiol. 2014 Feb;52(2):578-86. doi: 10.1128/JCM.02860-13.

7.

Extraordinary heterogeneity of virological outcomes in patients receiving highly antiretroviral therapy and monitored with the World Health Organization public health approach in sub-saharan Africa and southeast Asia.

Aghokeng AF, Monleau M, Eymard-Duvernay S, Dagnra A, Kania D, Ngo-Giang-Huong N, Toni TD, Touré-Kane C, Truong LX, Delaporte E, Chaix ML, Peeters M, Ayouba A; ANRS 12186 Study Group..

Clin Infect Dis. 2014 Jan;58(1):99-109. doi: 10.1093/cid/cit627.

8.

Seroprevalence of toxoplasmosis and rubella in pregnant women attending antenatal private clinic at Ouagadougou, Burkina Faso.

Linguissi LS, Nagalo BM, Bisseye C, Kagoné TS, Sanou M, Tao I, Benao V, Simporé J, Koné B.

Asian Pac J Trop Med. 2012 Oct;5(10):810-3. doi: 10.1016/S1995-7645(12)60148-5.

9.

Characterization of HIV-1 genotypes and antiretroviral drug-resistance mutations among patients in Burkina Faso.

Kagone TS, Hien H, Meda N, Diagbouga PS, Sawadogo A, Drabo J, Peeters M, Vergne L, Delaporte E, De Souza C, Gbeassor M, Simpore J.

Pak J Biol Sci. 2011 Mar 15;14(6):392-8.

PMID:
21902063
10.

Low prevalence rate of indeterminate serological human immunodeficiency virus results among pregnant women from Burkina Faso, West Africa.

Kania D, Fao P, Valéa D, Gouem C, Kagoné T, Hien H, Somda P, Ouédraogo P, Drabo A, Gampini S, Méda N, Diagbouga S, Van de Perre P, Rouet F; WHO/ANRS 1289 Kesho Bora Study Group in Burkina Faso..

J Clin Microbiol. 2010 Apr;48(4):1333-6. doi: 10.1128/JCM.01734-09.

11.

[Human immunodeficiency virus, hepatitis C virus and hepatitis B viruses in patients with sickle-cell disease in Togo].

Ségbéna AY, Prince-David M, Kagoné TS, Dagnra AY.

Transfus Clin Biol. 2005 Dec;12(6):423-6. French.

PMID:
16414299
Items per page

Supplemental Content

Loading ...
Support Center